medline.ch Onkologie Gynäkologische Tumoren

	Evidence-based prescription: optimal exercise type and dose for pain management in breast cancer survivors-a systematic review and dose-response network meta-analysis. BMC Cancer Huang H, Chen X, Wang Z, Zhang Y. PMID: 41353179 [PubMed - as supplied by publisher]
	Body and Mind Programme for recovery from breast cancer: Evaluation of the impact of health promotion intervention carried out in a multidisciplinary team on health-promoting behaviours: a quasi-randomised-controlled clinical trial. BMC Psychol Lévai T, Lázár G, Simonka Z, Paszt A, Horváth Z, Ottlakán A, Holczer A, Göncz, Börcsök N, Pipicz G, Látos M. PMID: 41353158 [PubMed - as supplied by publisher]
	Comparison of partial breast radiation modalities in women with early-stage breast cancer: a target trial emulation. J Natl Cancer Inst Shumway DA, Corbin KS, Shiraishi S, Farah MH, Fleti F, Hasan B, Firwana MM, Saadi S, Nayfeh T, Hegazi M, Waddle MR, Amundson AC, Vargas CE, Vallow LA, Oladeru OT, Hieken TJ, Park SS, Mutter RW, Murad MH, Wang Z. PMID: 41352976 [PubMed - as supplied by publisher]
	Evaluating the Clinical Utility of Node-RADS 1.0 for Axillary Lymph Node Assessment in Breast Cancer: Comparison with Conventional MRI Diagnosis. Br J Radiol Liao J, Liu C, Huang X, Ye Y, Xu Z, Liang Y, Liang C, Wu L. PMID: 41352974 [PubMed - as supplied by publisher]
	SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer. Int J Gynecol Cancer Chiva L, Ordas P, Mishra J, Ayhan A, Lee YY, Bogani G, Sp S, Lomnytska M, Stukan M, Fruscio R, Chura BF, Salcedo-Hernandez RA, De Iaco P, Haidopoulos D, Svintsitskiy V, Jain V, Stanciu P, Rawert FL, Akdemir C, Abdallah R, Chacon E, Minguez JA, Gil-Moreno A, Kharchenko K, Mofrad MH, Gebauer G, Díaz-Feijoo B, Scibilia G, Klaric M, , Saadeh FA, Mueller MD, Saarelainen S, Tejerizo García Á, Fotopoulou C, Coronado P, Dermikiran F, Goffin F, Tsolakidis D, Gonzalez-Martin A, SUROVA Study Group. PMID: 41352872 [PubMed - indexed for MEDLINE]
	Refining cell classification for cervical cancer detection using an improved high dimensional feature fusion approach. Med Eng Phys Singh S, Sahu C, Singh P, Mishra A, Mishra SK, Patnaik PK. PMID: 41352861 [PubMed - indexed for MEDLINE]
	Tuning sensitivity and limit of detection of nanoparticle dimer based on SiO(2)@Au core-shell for breast cancer diagnosis and prediction of treatment benefit. Med Eng Phys El Garrab C, Zekriti M. PMID: 41352854 [PubMed - indexed for MEDLINE]
	Ovarian cancer biosensors: established glycoproteins to emerging molecular biomarkers. Clin Chim Acta Jahanbani Y, Fathi F, Azizi H, Bastani P, Ranjbari F. PMID: 41352751 [PubMed - as supplied by publisher]
	Implementing decision aid use and shared-decision making in breast cancer screening: A scoping review. Patient Educ Couns Alkhaldi R, Pathak N, Mintsopoulos V, Fazelzad R, Schrager S, Villain P, Ivers N, Nadler MB. PMID: 41352313 [PubMed - as supplied by publisher]
	Enhancing Breast Cancer Research Through Snapshot Studies: Benefits and Challenges. Clin Breast Cancer Kramer GM, Heeling E, Volders JH, Peeters MTFDV. PMID: 41352225 [PubMed - as supplied by publisher]
	Emerging technologies for monitoring breast cancer response to neoadjuvant chemotherapy: a systematic scoping review. Breast Wright GC, Glover LT, Hubbard TJE. PMID: 41352211 [PubMed - as supplied by publisher]
	Exploring the application of PD-1/PD-L1 inhibitors for ovarian cancer. Cancer Treat Res Commun Miao X, Wang Z, Liu D, Ji S, Li J, Zhang S. PMID: 41352203 [PubMed - as supplied by publisher]
	Unraveling the microbiome's role in breast cancer progression and treatment response. Curr Probl Cancer Taki AG, Shareef A, Arora V, Oweis R, Jyothi SR, Singh U, Sahoo S, Chauhan AS, Alimova F, Sameer HN, Yaseen A, Athab ZH, Adil M. PMID: 41352125 [PubMed - as supplied by publisher]
	Shaping the future one slice at a time: How 3D organotypic tumour slice models are driving drug discovery in ovarian cancer. Transl Oncol Edwards M, Caruana P, Escar M, Céspedes MV. PMID: 41351993 [PubMed - as supplied by publisher]
	Machine-learning survival models for predicting time to recurrence in epithelial ovarian cancer. Gynecol Oncol Nakayama J, McGaughey M, Pindzola G, Miller E, Krivak T, Morse C, Crafton S, Wield A, Toole J, Summerscales T. PMID: 41351944 [PubMed - as supplied by publisher]
	Evaluating patient perspectives about the acceptability of a novel prognostic gene expression signature for high grade serous ovarian cancer: The OTTA-SPOT study. Gynecol Oncol Evans HE, Firriolo AM, Houweling R, Kelada L, Stannard G, Frawley J, McGill BC, Ramus SJ, Lee YC, Friedlander M, Duggan J, Wakefield CE. PMID: 41351943 [PubMed - as supplied by publisher]
	Clinical characteristics, treatment status and prognosis analysis of elderly patients with ovarian cancer: a real world clinical study. Discov Oncol Wang X, Xi L, Shen Y, Chen J, Xi R, Wang G. PMID: 41351814 [PubMed - as supplied by publisher]
	Effects of different intensity of resistance exercise on shoulder function and immune function in young and middle-aged postoperative breast cancer patients: a randomized control trial. Support Care Cancer Yijing F, Huiqian X, Hong L, Zirui Z, Shufang Z, Yang W, Zhou L. PMID: 41351700 [PubMed - indexed for MEDLINE]
	Late-Stage Diagnosis of Breast Cancer in Ghana: Needs for Patient and Public Education. J Cancer Educ Amamoo RS, Osei-Bonsu E, Klimentidis YC, Soliman AS. PMID: 41351654 [PubMed - as supplied by publisher]
	Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment. Clin Transl Sci Devireddy T, Lim C, Patel J, Tan IJ, Cohen BA. PMID: 41351479 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 321417

Seite 1 von 16071

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung